Todd Peck to Race SS Green Light Racing Entry at Phoenix
Pennsylvania Racer Brings Stopain and Arthritis Foundation to Team
Glenville, Penn. (November 6, 2012) – Peck Motorsports announced today that their driver, Todd Peck, will race the No. 08 Stopain/Arthritis Foundation Chevrolet in Friday night’s NASCAR Camping World Truck Series event, the Lucas Oil 150 at the Phoenix International Raceway. The truck will be fielded by veteran truck series team SS Green Light Racing. Peck will be making his debut at the one-mile oval.
Peck, who suffers from arthritis, will continue to have the support of Stopain and the Arthritis Foundation this weekend. He brings the partners to the Bobby Dotter-owned team for this race only. The collaboration allows Peck a guaranteed starting spot in Friday night’s event allowing him to gain additional experience in the series.
The SS Green Light Racing and No. 08 team have had success this season posting three top-10 finishes and one top-five finish. Peck will be looking to make his fifth start in the series.
“Racing for Bobby (Dotter) just makes a lot of sense this weekend,” said Peck. “We’re a growing team, with strong marketing capabilities, but Phoenix is a new track for me. Going here with a guaranteed starting spot will allow me to gain the experience I need and give our partners the value they are looking for. I am thankful for this opportunity this weekend.”
Dotter is also looking forward to partnering with the young driver.
“I have known Todd’s family for a long time,” said Dotter. “They have deep roots in NASCAR racing and Todd is getting used to the ropes of the truck series. This weekend will continue to help him grow and gain experience. We’ll make sure that we prepare a fast truck for all his partners and fans. I’m looking forward to Friday night.”
Friday’s race is schedule to air live on SPEED Channel beginning at 7:30 p.m. ET.
Stopain®, a leading topical pain reliever, is available in four formulations: Stopain Spray, Stopain Extra Strength Spray, Stopain Extra Strength Roll-On and the new Stopain Gel. The spray and roll-on formulations are top-sellers in the topical analgesic category.
Stopain is a product with a highly loyal customer base and strong history of success. The brand was established in 1991, when the product was developed by a pharmacist in Southern California. Recommended by doctors and pharmacists for its immediate and long-lasting pain relief, Stopain provides relief for minor pains and stiffness of arthritis, muscle aches and back pain. Stopain products are made 100% in the USA and can be purchased nationally at more than 25,000 independent pharmacies and national chain drug stores, including Walgreens, Wal-Mart, CVS, Meijer, and Rite-Aid Pharmacies. To learn more about Stopain, visit www.stopain.com
About the Arthritis Foundation
Striking one in every five adults and 300,000 children, arthritis is the nation’s leading cause of disability. The Arthritis Foundation (www.arthritis.org) is committed to raising awareness and reducing the impact of this serious, painful and unacceptable disease, which can severely damage joints and rob people of living life to its fullest. The Foundation funds life-changing research that has restored mobility in patients for more than six decades; fights for health care policies that improve the lives of the millions who live with arthritis; and partners with families to provide empowering programs and information.
Juvenile Arthritis (JA) affects more than 300,000 children in the U.S. JA is a term to describe the many autoimmune and inflammatory conditions that can develop in children ages 16 and younger. There are several different types of JA.